Key result
Advanced imaging enhances stem cell delivery, engraftment tracking, and efficacy assessment for cardiac regeneration.
Answers are grounded in this paper and cite their sources.
Stem cells have been touted as the holy grail of medical therapy, with promises to regenerate cardiac tissue, but it appears the jury is still out on this novel therapy. Using advanced imaging technology, scientists have discovered that these cells do not survive nor engraft long-term. In addition, only marginal benefit has been observed in large-animal studies and human trials. However, all is not lost. Further application of advanced imaging technology will help scientists unravel the mysteries of stem cell therapy and address the clinical hurdles facing its routine implementation. In this review, we will discuss how advanced imaging technology will help investigators better define the optimal delivery method, improve survival and engraftment, and evaluate efficacy and safety. Insights gained from this review may direct the development of future preclinical investigations and clinical trials.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2011) conducted a review in Cardiac tissue regeneration. Advanced imaging technology was evaluated. Advanced imaging technology may help define optimal delivery methods, improve engraftment, and evaluate the efficacy and safety of stem cell therapy for cardiac tissue regeneration.
Synapse has enriched 10 related papers. Consider them for comparative context: